Strong LC / RB Figure 3 / Novartis / Hearn SA / Simmons / Knudsen / Shurtleff SA / Pfizer / RB / BioMed Central Ltd. / Sylvester KG / Creative Commons / /
Country
United States / / /
Event
Product Issues / FDA Phase / /
Facility
Sicinski’s laboratory / clinic The / University of Texas Southwestern Medical Center / /
IndustryTerm
Similar tools / prognostic tool / breast cancer management / treatment of metastatic disease / /
MedicalCondition
specifically prevented tumor / DCIS / JE / Residual Disease / retinoblastoma / HER2 Negative Breast Cancer / retinoblastoma gene function / pediatric eye tumor / Estrogen receptor-positive breast cancer / inhibitor breast cancer / Her2-positive cancers / Retinoblastoma tumor / estrogen receptor-positive disease / ductal carcinoma / B breast cancer / intact retinoblastoma tumor suppressor / metastatic disease / Her2 disease / melanoma / different breast cancer / diagnosed breast cancer / RB-deficient tumor / Her2-positive disease / Such tumors / B cancers / Advanced Breast Cancer / breast cancer / Advanced ER+ Breast Cancer / recurrent disease / tumor / several different diseases / cancer / tumors / such rapidly proliferating tumors / hepatocellular carcinoma / retinoblastoma gene-deficient cells / retinoblastoma gene / retinoblastoma protein functions / human cancer / basal-like cancers / osteosarcoma / pancreatic cancers / aggressive tumor / Invasive breast cancers / invasive breast cancer / opportunity Her2-positive breast cancer / Her2-positive breast cancers / Her2-positive breast cancer / retinoblastoma tumour-suppressor genes / ER-positive breast cancer / ERpositive breast cancer / advanced disease / aggressive/ rapid tumor / Human retinoblastoma susceptibility gene / invasive disease / canonical retinoblastoma tumor suppressor / TNBC tumors / invasive cancer / Triple-negative breast cancer TNBC / J Cancer / ER-positive disease / retinoblastoma protein / osteosarcomas / least three distinct diseases / diagnosed breast cancers / basal cancers / B tumors / triple-negative breast cancer / Breast Cancer ER-positive / cancers / breast cancers / ER-positive breast cancers / B breast cancers / disease / retinoblastoma tumor suppressor / mammary tumors / tumour / REVIEW Retinoblastoma tumor / aggressive disease / lung cancer / aggressive DCIS / rapidly growing tumors / positive breast cancers / benign Nevi / /
Witkiewicz and Knudsen Breast Cancer Research 2014, 16:207 http://breast-cancer-research.com/contentREVIEW Retinoblastoma tumor suppressor pathway in